Protected: About Randox

Home - General - Page 3

Neonatal Health With Randox

Neonatal screening is vital for the overall health of newborn babies. Although it is not a mandatory procedure it is highly recommended to detect infections and diseases that can have devastating consequences if not diagnosed soon after birth. Randox’s range of neonatal reagents include CRP, Bilirubin and Complement C4 that are essential in the detection of neonatal lupus and jaundice; which if left undetected can lead to sickle cell anaemia, rubella and even syphilis. Armed with these specific and high quality reagents and Randox Quality Control material ensures not only the early detection of such diseases but also the accuracy and reliability of the laboratory test results that can help to ensure that your baby gets the best start in life.

Neonatal Health: Reagents

Randox Reagents have the highest quality reagents on the market and a test menu comprising of over 118 assays covering over 100 disease markers. Our specific reagents for neonatal health include, G-6-PDH, IgEBilirubin, Copper, Complement C4 & C3IgA , CRP and CRP full range. With flexible pack sizes and a comprehensive list of analyser applications available, you are sure to find what you are looking for.

Neonatal Health: RX series

Randox has developed the RX series of clinical chemistry analysers for superior semi-automated and fully automated testing. The RX series extensive dedicated test menu goes beyond routine testing and has many unique and high-performance tests available. Our range of tests covers several parameters to assess neonatal health.

Neonatal Health: Quality Control

Randox Liquid Bilirubin Control provides a true third party solution for the measurement of bilirubin. Designed to deliver unbiased and independent results, it ensures your instrument is accurate and reliable when testing real patient samples. An elevated bilirubin control is also available to monitor accuracy at higher levels enabling early medical intervention when it matters.

Neonatal Health: RIQAS

RIQAS is the largest international external quality assessment scheme with 45,000 participants worldwide. With 33 comprehensive EQA programmes and world renowned consolidation, it reduces the number of individual programmes required. RIQAS programmes are available to compliment neonatal health tests.


NeoNatal

Metabolic health is a term used to describe a collection of  required chemical reactions that take place in all living organisms. A metabolic disorder develops when an abnormal chemical reaction occurs which alters the normal metabolic process.

Did you know?

 Approximately 20-25% of the world’s adult population have metabolic syndrome?

 

Randox has developed the RX series of clinical chemistry analysers for superior semi-automated and fully automated testing. The RX series extensive dedicated test menu goes beyond routine testing and has many unique and high-performance tests available. Our range of tests covers several parameters to assess your overall metabolic health.

Metabolic Health Profile

Albumin Chloride Potassium
Alkaline Phosphatase  C0Total Sodium
ALT Creatinine Total Bilirubin
AST (GOT) Glucose Total Protein
Direct Bilirubin Lactate Urea
Calcium

The RX series clinical chemistry analysers provide laboratories with a robust and smart solution ensuring you maintain a consistent workflow and can provide accurate results first time, every time. Offering excellent customer support services, our trained engineers are on hand to work with you in preserving the continuity of your operations while maximising the potential of your RX series instrument.Our world-famous test menu of high quality reagents ensures excellence in patient care, guaranteeing unrivalled precision and accuracy reducing costly test re-runs or misdiagnosis and offering complete confidence in results.

For more information visit: https://www.randox.com/clinical-chemistry-analysers/

Metabolic syndrome comprises of risk factors such as high blood pressure, high blood sugar/cholesterol and abdominal fat, which together, can lead to serious long term problems including an increased risk of heart disease, stroke and developing type 2 diabetes. Randox have developed an extensive range of reagents to accurately diagnose and monitor metabolic health, with the aim that patients can take the appropriate measurements to improve their health.

All reagents are available for use on a wide range of third party biochemistry analysers. Contact us to request an application for your specific analyser.

Adiponectin

Adiponectin is a clinical diagnostic biomarker for metabolic risk assessment. Adiponectin is solely excreted by adipocytes and is a protein hormone with anti-inflammatory and insulin-sensitising properties. It plays an important role in a number of metabolic processes such as glucose regulation and fatty acid oxidation. Levels of adiponectin have been linked with several pathologies including metabolic syndrome, cancer and cardiovascular disease, as levels are inversely correlated with Abdominal Visceral Fat (AVF). Randox is one of the only manufacturers of adiponectin in an automated biochemistry format, removing the inconvenience and time consumption associated with traditional ELISA-based testing.

For more information visit: https://www.randox.com/adiponectin/

Small-dense LDL (sLDL) Cholesterol

Small-dense LDL cholesterol is a vital cardiac risk marker, usually tested in patients with prediabetes or metabolic syndrome. Randox sLDL utilises the “Denka Seiken” method which produces results in less than ten minutes. Research has shown individuals with a predominance of sLDL have a 3-fold increased risk of myocardial infarction (MI), even for those who HDL, LDL, Total Cholesterol and Triglyceride levels are considered ‘normal’. Elevated levels of sLDL are associated with a sedentary lifestyle, a diet high in saturated fat, insulin resistance, pre-diabetes and genetic disposition. Measurement of sLDL allows the clinician to get a more comprehensive picture of lipid risk factors and tailor treatment accordingly. Reducing LDL levels reduce the risk of both CVD and MI.

For more information visit: www.randox.com/sldl-cholesterol/

TxBCardio™

Randox TxBCardio™ is used to assess the level of aspirin resistance in patients at risk of cardiovascular disease. Aspirin resistance is a serious clinical problem and is estimated to affect 25-20% of patients on a low dosage. It is important to assess aspirin resistance as this may be anticipated in patients with metabolic syndrome. The identification of these patients can be significantly improved through the use of Randox TxBCardio™ as the results generated can be used to enable timely intervention by clinicians and they can focus on anti-platelet therapy.

For more information visit: https://www.randox.com/txbcardio/

 

Other metabolic health tests:

  • Albumin
  • Alkaline Phosphatase
  • ALT
  • AST (GOT)
  • Direct Bilirubin
  • Calcium
  • Chloride
  • CO2 Total
  • Creatinine
  • Glucose
  • Lactate
  • Potassium
  • Sodium
  • Total Bilirubin
  • Total Protein
  • Urea

      When diagnosing and monitoring metabolic-related complications such as Diabetes and Cardiovascular Disease (CVD), it is vital that laboratories have a robust Quality Control (QC) system in place to ensure the accuracy and reliability of the results produced. As a world leading manufacturer of QC solutions including Third Party Controls and External Quality Assessment (EQA), our extensive product portfolio is designed to help reduce costs and time without compromising on quality.

      Diabetes

      Liquid HbA1c Control

      • Liquid ready-to-use format ideal for use in the lab or at the POC
      • Whole blood sample matrix commutable with that of the patient sample
      • Assayed control with values available for HPLC
      • Convenient bi-level pack accurately covering the patient reportable range
      • Open vial stability of 30 days ultimately helping to reduce waste and costs
      • For more information visit: https://www.randox.com/liquid-hba1c-quality-control/

      Glycated Hemoglobin EQA Programme

      • Monthly analysis ensuring early identification of test system errors
      • Maximised peer groups for comparative performance assessment
      • Reports available within 72 hours allowing corrective action to be taken immediately
      • User-friendly reports delivering at-a-glance performance assessment
      • For more information visit: https://www.randox.com/hba1c-eqa/

      CVD risk

      Lipid Control

      • Covers the complete lipid profile
      • True third party control ensuring unbiased performance assessment with any instrument or method
      • Manufactured from 100% human serum ensuring a matrix commutable with the patient sample
      • Free from Sodium Azide which can interfere with direct clearance methods of HDL and LDL Cholesterol
      • Three clinically significant levels available covering low, borderline and high risk levels of HDL and LDL Cholesterol
      • For more information visit: https://www.randox.com/lipid-quality-control/

      Lipid EQA Programme

      • Covers the complete lipid profile with a choice of reporting just three parameters at a reduced cost
      • Monthly analysis ensuring early identification of test system errors
      • Maximised peer groups for comparative performance assessment
      • Reports available within 72 hours allowing corrective action to be taken immediately
      • User-friendly reports delivering at-a-glance performance assessment
      • For more information visit: https://www.randox.com/lipids-eqa/

      Our Randox Health clinics offer comprehensive health testing as part of our Signature, Everyman and Everywoman packages to  give you a comprehensive picture of your overall metabolic health. Our clinics utilise the same cutting-edge tests and quality control that we have available to clinical laboratories globally, as well as our patented Biochip Array Technology (BAT).

      For more information visit: https://www.randoxhealth.com/

      A common misconception surrounding metabolic health is that it refers solely to your weight, and if you are overweight you are considered to be unhealthy. But in actual fact this may not be entirely true. Good metabolism means that your body is in good overall health, which doesn’t account for just your weight! Common metabolic disorders include genetic metabolic disorders, diabetes and metabolic syndrome. Understanding and testing to see how well your metabolism is functioning is key to ensuring long lasting health.

      Genetics

      There are a number of genetic metabolic disorders caused by mutations of single genes. Examples of common disorders include Gaucher’s disease, hemochromatosis and cystic fibrosis. Gaucher’s disease is a genetic disorder that affects the body’s ability to break down fat that can accumulate in the liver/spleen and bone marrow. Hemochromatosis is a condition that is caused by the over-absorption and build-up of iron while cystic fibrosis is a metabolic disorder that appears as a result of a build-up of mucus in lungs/liver and intestines. Each of these metabolic disorders affect certain organs from functioning properly and therefore your overall healthiness.

      Diabetes

      Type 2 diabetes is one of the most common types of  metabolic disorders in the world that is expected to affect 592 million people by 2035. It is characterised by high blood sugar, insulin resistance or a lack of insulin being produced by the pancreas. Insulin resistance occurs when the body isn’t able to use insulin the right way which increases blood glucose levels. Insulin is needed for cells to take in glucose (sugar) from the bloodstream and convert it into energy. Over time this lack of insulin can damage the organs in your body.

      Metabolic Syndrome

      Metabolic syndrome (also known as syndrome X, Reaven’s syndrome, and CHAOS) is not a disease but a collection of risk factors that affect your health; these include high blood pressure, high blood sugar/cholesterol and abdominal fat. Left untreated, these risk factors, together, can lead to long term serious problems including an increased risk of heart disease, stroke and developing type 2 diabetes.

      Can you improve your metabolic health?

      Yes! The good news is that if you discover that your metabolic health is not up to scratch you can improve it through a combination of diet, exercise and lifestyle adjustments such as:

      • 30 minutes of moderate to intense exercise 5-7 times a week
      • Low-dose aspirin to reduce your risk of stroke or heart attack
      • Quit smoking
      • Medication for blood pressure/cholesterol/ blood sugar
      • Limit alcohol intake
      • Eat a healthy balanced diet

      Related Products 

      follow us on social media


      Metabolic Health

      Metabolic health is a term used to describe a collection of  required chemical reactions that take place in all living organisms. A metabolic disorder develops when an abnormal chemical reaction occurs which alters the normal metabolic process.

       

      Did you know?

       Approximately 20-25% of the world’s adult population have metabolic syndrome?

       

      A common misconception surrounding metabolic health is that it refers solely to your weight, and if you are overweight you are considered to be unhealthy. But in actual fact this may not be entirely true. Good metabolism means that your body is in good overall health, which doesn’t account for just your weight! Common metabolic disorders include genetic metabolic disorders, diabetes and metabolic syndrome. Understanding and testing to see how well your metabolism is functioning is key to ensuring long lasting health.

      Genetics

      There are a number of genetic metabolic disorders caused by mutations of single genes. Examples of common disorders include Gaucher’s disease, hemochromatosis and cystic fibrosis. Gaucher’s disease is a genetic disorder that affects the body’s ability to break down fat that can accumulate in the liver/spleen and bone marrow. Hemochromatosis is a condition that is caused by the over-absorption and build-up of iron while cystic fibrosis is a metabolic disorder that appears as a result of a build-up of mucus in lungs/liver and intestines. Each of these metabolic disorders affect certain organs from functioning properly and therefore your overall healthiness.

      Diabetes

      Type 2 diabetes is one of the most common types of  metabolic disorders in the world that is expected to affect 592 million people by 2035. It is characterised by high blood sugar, insulin resistance or a lack of insulin being produced by the pancreas. Insulin resistance occurs when the body isn’t able to use insulin the right way which increases blood glucose levels. Insulin is needed for cells to take in glucose (sugar) from the bloodstream and convert it into energy. Over time this lack of insulin can damage the organs in your body.

      Metabolic Syndrome

      Metabolic syndrome (also known as syndrome X, Reaven’s syndrome, and CHAOS) is not a disease but a collection of risk factors that affect your health; these include high blood pressure, high blood sugar/cholesterol and abdominal fat. Left untreated, these risk factors, together, can lead to long term serious problems including an increased risk of heart disease, stroke and developing type 2 diabetes.

      Can you improve your metabolic health?

      Yes! The good news is that if you discover that your metabolic health is not up to scratch you can improve it through a combination of diet, exercise and lifestyle adjustments such as:

      • 30 minutes of moderate to intense exercise 5-7 times a week
      • Low-dose aspirin to reduce your risk of stroke or heart attack
      • Quit smoking
      • Medication for blood pressure/cholesterol/ blood sugar
      • Limit alcohol intake
      • Eat a healthy balanced diet

      Related Products 

      Randox has developed the RX series of clinical chemistry analysers for superior semi-automated and fully automated testing. The RX series extensive dedicated test menu goes beyond routine testing and has many unique and high-performance tests available. Our range of tests covers several parameters to assess your overall metabolic health.

      Metabolic Health Profile

      Albumin Chloride Potassium
      Alkaline Phosphatase  C0Total Sodium
      ALT Creatinine Total Bilirubin
      AST (GOT) Glucose Total Protein
      Direct Bilirubin Lactate Urea
      Calcium

      The RX series clinical chemistry analysers provide laboratories with a robust and smart solution ensuring you maintain a consistent workflow and can provide accurate results first time, every time. Offering excellent customer support services, our trained engineers are on hand to work with you in preserving the continuity of your operations while maximising the potential of your RX series instrument.Our world-famous test menu of high quality reagents ensures excellence in patient care, guaranteeing unrivalled precision and accuracy reducing costly test re-runs or misdiagnosis and offering complete confidence in results.

      For more information visit: https://www.randox.com/clinical-chemistry-analysers/

      Metabolic syndrome comprises of risk factors such as high blood pressure, high blood sugar/cholesterol and abdominal fat, which together, can lead to serious long term problems including an increased risk of heart disease, stroke and developing type 2 diabetes. Randox have developed an extensive range of reagents to accurately diagnose and monitor metabolic health, with the aim that patients can take the appropriate measurements to improve their health.

      All reagents are available for use on a wide range of third party biochemistry analysers. Contact us to request an application for your specific analyser.

      Adiponectin

      Adiponectin is a clinical diagnostic biomarker for metabolic risk assessment. Adiponectin is solely excreted by adipocytes and is a protein hormone with anti-inflammatory and insulin-sensitising properties. It plays an important role in a number of metabolic processes such as glucose regulation and fatty acid oxidation. Levels of adiponectin have been linked with several pathologies including metabolic syndrome, cancer and cardiovascular disease, as levels are inversely correlated with Abdominal Visceral Fat (AVF). Randox is one of the only manufacturers of adiponectin in an automated biochemistry format, removing the inconvenience and time consumption associated with traditional ELISA-based testing.

      For more information visit: https://www.randox.com/adiponectin/

      Small-dense LDL (sLDL) Cholesterol

      Small-dense LDL cholesterol is a vital cardiac risk marker, usually tested in patients with prediabetes or metabolic syndrome. Randox sLDL utilises the “Denka Seiken” method which produces results in less than ten minutes. Research has shown individuals with a predominance of sLDL have a 3-fold increased risk of myocardial infarction (MI), even for those who HDL, LDL, Total Cholesterol and Triglyceride levels are considered ‘normal’. Elevated levels of sLDL are associated with a sedentary lifestyle, a diet high in saturated fat, insulin resistance, pre-diabetes and genetic disposition. Measurement of sLDL allows the clinician to get a more comprehensive picture of lipid risk factors and tailor treatment accordingly. Reducing LDL levels reduce the risk of both CVD and MI.

      For more information visit: www.randox.com/sldl-cholesterol/

      TxBCardio™

      Randox TxBCardio™ is used to assess the level of aspirin resistance in patients at risk of cardiovascular disease. Aspirin resistance is a serious clinical problem and is estimated to affect 25-20% of patients on a low dosage. It is important to assess aspirin resistance as this may be anticipated in patients with metabolic syndrome. The identification of these patients can be significantly improved through the use of Randox TxBCardio™ as the results generated can be used to enable timely intervention by clinicians and they can focus on anti-platelet therapy.

      For more information visit: https://www.randox.com/txbcardio/

       

      Other metabolic health tests:

      • Albumin
      • Alkaline Phosphatase
      • ALT
      • AST (GOT)
      • Direct Bilirubin
      • Calcium
      • Chloride
      • CO2 Total
      • Creatinine
      • Glucose
      • Lactate
      • Potassium
      • Sodium
      • Total Bilirubin
      • Total Protein
      • Urea

          When diagnosing and monitoring metabolic-related complications such as Diabetes and Cardiovascular Disease (CVD), it is vital that laboratories have a robust Quality Control (QC) system in place to ensure the accuracy and reliability of the results produced. As a world leading manufacturer of QC solutions including Third Party Controls and External Quality Assessment (EQA), our extensive product portfolio is designed to help reduce costs and time without compromising on quality.

          Diabetes

          Liquid HbA1c Control

          • Liquid ready-to-use format ideal for use in the lab or at the POC
          • Whole blood sample matrix commutable with that of the patient sample
          • Assayed control with values available for HPLC
          • Convenient bi-level pack accurately covering the patient reportable range
          • Open vial stability of 30 days ultimately helping to reduce waste and costs
          • For more information visit: https://www.randox.com/liquid-hba1c-quality-control/

          Glycated Hemoglobin EQA Programme

          • Monthly analysis ensuring early identification of test system errors
          • Maximised peer groups for comparative performance assessment
          • Reports available within 72 hours allowing corrective action to be taken immediately
          • User-friendly reports delivering at-a-glance performance assessment
          • For more information visit: https://www.randox.com/hba1c-eqa/

          CVD risk

          Lipid Control

          • Covers the complete lipid profile
          • True third party control ensuring unbiased performance assessment with any instrument or method
          • Manufactured from 100% human serum ensuring a matrix commutable with the patient sample
          • Free from Sodium Azide which can interfere with direct clearance methods of HDL and LDL Cholesterol
          • Three clinically significant levels available covering low, borderline and high risk levels of HDL and LDL Cholesterol
          • For more information visit: https://www.randox.com/lipid-quality-control/

          Lipid EQA Programme

          • Covers the complete lipid profile with a choice of reporting just three parameters at a reduced cost
          • Monthly analysis ensuring early identification of test system errors
          • Maximised peer groups for comparative performance assessment
          • Reports available within 72 hours allowing corrective action to be taken immediately
          • User-friendly reports delivering at-a-glance performance assessment
          • For more information visit: https://www.randox.com/lipids-eqa/

          Our Randox Health clinics offer comprehensive health testing as part of our Signature, Everyman and Everywoman packages to  give you a comprehensive picture of your overall metabolic health. Our clinics utilise the same cutting-edge tests and quality control that we have available to clinical laboratories globally, as well as our patented Biochip Array Technology (BAT).

          For more information visit: https://www.randoxhealth.com/

          follow us on social media


          Renal Function and Health

          Renal Health

          Your kidneys are vital for survival, they filter waste substances out of your blood and balance the levels of salts and water in our bodies. Your kidneys filter around 180 litres of blood every day, control the production of red blood cells and release hormones that regulate blood pressure – it’s little wonder, then, the importance placed on looking after such a vital organ.

          Did you know?

          Around 1 in 8 people in the UK will develop Chronic Kidney Disease (CKD)

          Kidney Disease can affect people of all ages and races, 10% of the population worldwide is affected by Chronic Kidney Disease (CKD.) Since Kidney Disease can sneak up without symptoms it has been labelled a silent killer, a person can lose up to 90% of their kidney function before experiencing any signs or symptoms.

          As kidney disease gets worse, wastes can build up in your blood and make you feel sick. You may develop additional problems such as high blood pressure, anemia, weak bones, poor nutritional health and nerve damage. Kidney disease also increases your risk of developing heart or blood vessel disease. These problems often develop slowly and will often lead to kidney failure.

          The two main causes of CKD are diabetes and high blood pressure, which are responsible for up to two-thirds of cases, other causes include inherited kidney diseases and malformations at birth.

           

          How is Chronic Kidney Disease detected?

          Early detection and treatment is crucial to keep kidney disease from developing into kidney failure, some simple tests can be carried out to detect early kidney disease. These are;

          1. A urine test to check if there is any protein present
          2. A blood test to measure levels of creatinine

          The best treatment is early detection when CKD can be slowed or stopped, however once kidneys fail, treatment with dialysis or a kidney transplant is needed. 8 of 10 people on the transplant list are waiting for a kidney, the average wait for a new kidney is 3 years, and every day one kidney patient will die waiting for a transplant.

           

          Reduce your risk of developing CKD

          Your kidneys are vital to your overall health, so it’s important to look after them. There are 5 simple steps that can help you keep them in good shape;

          1. Stay hydrated
          2. Maintain a balanced diet and keep your weight in check
          3. Monitor your blood pressure
          4. Quit Smoking
          5. Limit your alcohol intake

          Related Products 

          Randox has developed the RX series of clinical chemistry analysers for superior semi-automated and fully automated testing. The RX series extensive dedicated test menu goes beyond routine testing and has many unique and high-performance tests available. Our range of tests covers several parameters to assess renal health.

          Renal Function

          Albumin Creatinine Enzymatic IgG Phosphorus (Inorganic)
          Ammonia Creatinine (Jaffe) LDH Urinary Protein
          Beta-2 Microglobulin Cystatin C Magnesium Urea
          Calcium Glucose Potassium Uric Acid
          Chloride HbA1c/Hb Sodium

          Our world-famous test menu of high quality reagents ensures excellence in patient care, guaranteeing unrivalled precision and accuracy reducing costly test re-runs or misdiagnosis and offering complete confidence in results.

          The RX series clinical chemistry analysers provide laboratories with a robust and smart solution ensuring you maintain a consistent workflow and can provide accurate results first time, every time. Offering excellent customer support services, our trained engineers are on hand to work with you in preserving the continuity of your operations while maximising the potential of your RX series instrument.

          For more information visit: https://www.randox.com/clinical-chemistry-analysers/

           

           

          Kidney disorders can develop and advance overtime without any signs and the symptoms are not recognised as being associated with renal impairment. Kidney health and regular renal screening is important to enable renal impairment to be detected in its earliest stages to prevent renal failure.  Randox offers a comprehensive range of high performance reagents for the detection and characterisation of renal function problems.

          All reagents are available for use on a wide range of third party biochemistry analysers. Contact us to request an application for your specific analyser.

          Cystatin C

          Cystatin C is a useful marker where creatinine measurements are unsuitable e.g. patients who are obese, malnourished, have liver cirrhosis or reduced muscle mass.  Cystatin C also does not have a ‘blind area’ unlike creatinine – up to 50% of renal function can be lost before sufficient creatinine levels are detectable.  Cystatin C is extremely sensitive to small changes in Glomerular Filtration Rate (GFR) and so is capable of detecting early stages of renal impairment.

          For more information on Cystatin C, visit: www.randox.com/cystatin-c

          Enzymatic Creatinine

          Creatinine clearance in the kidneys gives a measurement of the GFR which is the standard marker for renal function.  The enzymatic method offers superior specificity when compared to the traditional Jaffe method.  Other benefits of the enzymatic method over the Jaffe method includes: limited interferences from bilirubin, haemoglobin, Intralipid® and Triglycerides making the assay more suitable for neonatal samples, eliminates the need for urea determination, highly specific and does not overestimate serum creatinine.

          For more information on Enzymatic Creatinine, visit: www.randox.com/creatinine

          Microalbumin

          The detection of albumin in urine can be an indicator of kidney injury, as damage to the glomerular basement membrane results in albumin seeping out of the kidneys into urine. Sustained elevations of urinary albumin concentrations are called Microalbuminuria. The Randox Microalbumin test is an excellent marker of kidney disease and can identify individuals with diabetic nephropathy approximately 5-10 years earlier than proteinuria tests reducing the incidence of end stage renal disease.   The American Diabetes Association and Diabetes UK recommend that all diabetics are screened for microalbuminuria on a yearly basis.

          For more information on Microalbumin, visit: www.randox.com/microalbumin

          Renal Testing Panel

          • Cystatin C
          • Creatinine Enzymatic
          • Creatinine Jaffe
          • Microalbumin
          • Total Urinary Protein
          • Urea
          • Sodium
          • Potassium
          • Albumin
          • Ammonia
          • β₂ Microglobulin
          • Calcium
          • Chloride
          • Glucose
          • HbA1c
          • IgG
          • LDH
          • Magnesium
          • Phosphorus (Inorganic)
          • Uric Acid

          When diagnosing and monitoring Chronic Kidney Disease (CKD), it is vital that laboratories have a robust Quality Control (QC) system in place to ensure the accuracy and reliability of the results produced. The Acusera Chemistry and Urine Controls have been designed to cover a wide range of kidney function tests at clinical decision levels eliminating the need for additional low level controls at extra expense.

          Our range of Chemistry Controls contain up to 100 analytes and cover a wide range of kidney function tests. Available in a choice of liquid or lyophilised formats, options are available to suit all laboratory sizes and budgets.

          Our portfolio of Urine Controls cover the full range of clinical testing, manufactured from 100% human serum a matrix similar to that of the patient is guaranteed. They are available in both liquid ready-to-use and lyophilised formats, making them ideal for use at the point-of-care and in the laboratory.

          Common kidney function parameters we cover include;

          • Albumin
          • Urea/BUN
          • Bicarbonate
          • Calcium
          • Chloride
          • Creatinine
          • Creatinine Clearance
          • Cystatin C
          • Glucose
          • Phosphate
          • Potassium
          • Sodium
          • Urine Albumin
          • Albumin/Creatinine Ratio
          • Beta-2 Microglobulin
          • Urinalysis
          • Urine Protein

          For more information, contact us at acusera@randox.com

          We also have corresponding RIQAS Chemistry and Urine Programmes which cover the common kidney function tests, including;

          RIQAS General Clinical Chemistry Programme

          The RIQAS General Clinical Chemistry EQA programme is designed to monitor the performance of up to 52 parameters. Three flexible yet cost effective programme options are available.

          • Accredited to ISO/IEC 17043
          • Lyophilised for enhanced stability
          • Human based serum
          • Bi-weekly reporting
          • Submit results and view reports online via RIQAS.Net
          • Register up to five instruments at no extra cost
          • Reference method values are provided for selected parameters/lots

          For more information, visit our RIQAS General Clinical Chemistry Programme page.

          RIQAS Human Urine Programme

          The RIQAS Human Urine EQA programme is designed to monitor the performance of up to 25 routine chemistry assays in urine.

          • Accredited to ISO/IEC 17043
          • Lyophilised for enhanced stability
          • 100% human urine
          • Bi-weekly reporting
          • Submit results and view reports online via RIQAS.Net
          • Register up to five instruments at no extra cost

          For more information, visit our RIQAS Human Urine Programme page

           

          Our Randox Health clinics offer comprehensive health testing as part of our Signature, Everyman and Everywoman packages to identify and assess risk of developing Kidney Disease. Our clinics utilise the same cutting-edge tests and quality control that we have available to clinical laboratories globally, as well as our patented Biochip Array Technology (BAT).

          For more information visit: https://www.randoxhealth.com/

          follow us on social media


          Simple health checks, sophisticated science at Randox Health

          What is health care? When we think of caring for our health, we think of going to the doctor when we feel ill. The healthcare cycle weā€™re accustomed to is one where we wait for symptoms to present themselves and then we visit a doctor, hoping to be prescribed medication to limit our symptoms.

          Is this really health care? Are we really caring for our bodies in the best way possible by waiting for illness to manifest itself? What if we could properly look after our bodies by taking action early to stop illness in its tracks?

          The key to this is identifying indicators of pre-illness, and the technology that allows you to do this is now available directly to you through Randox Health.

          After investing over Ā£220 million in the invention and production of revolutionary blood-science technology, a single Randox Health check will deliver a complete picture of your health ā€“ as it is now and crucially how it is likely to develop in the future.

          Randox Health has proven that signs of disease or irregularity can be caught at their earliest stage. This means that, with early action, some cases of illness can even be prevented altogether. Our health checks include, but are not limited to, cancer surveillance, fertility monitoring, heart health, nutrition, digestive and diabetes health.

          In other words, from one health check, youā€™ll receive up to 350 results and afterwards avail of expert advice from the Randox scientists or a Randox Health GP. Not only that, but a complete 12-month programme and repeat testing come as standard so you can have full confidence that you are really taking care of yourself.

          Look out for our new ā€˜Health Made Simpleā€™ blogs beginning next week, where weā€™ll be delving in to the sophisticated science and diagnostic tests that power each Randox Health check.

          Youā€™ll find out about our Everyman, Everywoman and our Signature health checks, as well as our Specialised testing options which focus on specific health issues.

          Find out more and start your Randox Health journey today.

          For further information, please contact the Randox PR team via email: randoxpr@randox.com or phone 028 9442 2413


          Randox is improving health worldwide

          With over 35 years’ experience in developing accurate and cutting-edge technology and an aim to revolutionise healthcare worldwide, Randox remains firmly committed to advancing diagnostic solutions. Our passion for innovation, expertise and investment in R&D enables us to continually develop new products and adapt quickly to meet market demands and evolve for the future. By improving diagnostics we want to enable earlier and more accurate clinical decision making, patient outcomes and burdens on current health services.

          Third party biochemistry reagents

          Since inception in 1982 our range of  biochemistry reagents has grown significantly to now having the highest quality reagents on the market and a test menu comprising of over 118 assays covering over 100 disease markers. These include proteins, lipids, therapeutic drug monitoring, drugs of abuse, antioxidants, coagulation, diabetes and veterinary testing. Through our advancements in laboratory innovation we aim to discover more sensitive and significant biomarkers that meet the demands of current and future diagnostics to enable laboratories to change the way they operate.

          Complete QC solutions

          Randox Quality Control offers a complete laboratory QC solution comprising Acusera true third party controls, Acusera 24.7 interlaboratory data management, and RIQAS, the world’s largest External Quality Assessment scheme, allowing labs to fulfil their entire QC requirements, saving time and money.  In a world where disease is pervasive, we understand the importance of accurate diagnosis; not only to ensure the correct treatment, but also allow preventative measures to be taken, reducing the development of disease. Our range of quality controls expand in line with our extensive range of reagents

          Excellence in clinical chemistry testing

          The RX series range of clinical chemistry analysers were designed and developed to provide excellence in patient care by ensuring unrivalled precision and accuracy to meet the growing demands of the ever growing in vitro diagnostic industry. The series comprises of 5 analysers, the RX monaco, RX imola, RX misano, RX daytona+ and the RX modena, offering both semi-automated (RX misano) and automated solutions to laboratories across 120 countries. Renowned for its quality and reliability, the RX series boosts an extensive clinical chemistry test menu that includes routine chemistries, specific proteins, lipids, therapeutic drugs, drugs of abuse, antioxidants and diabetes testing.

          Multiplex Immunoassay Testing

          Our position as pioneers in the health industry prevails with our revolutionary Biochip Array Technology (BAT) and Evidence Series range of biochip analysers which include the Evidence, the Evidence MultiSTAT, the Evidence Investigator and the Evidence Evolution. BAT is an innovative assay technology which utilises multiplex testing methodology in a rapid, accurate and easy-to-use format.  Designed to work across a range of matrices including urine, whole blood and oral fluid, this revolutionary technology is transforming laboratories worldwide by providing an unrivalled increase in patient information per sample.

          Randox’s commitment to continuous scientific discovery and ability to transition with the demands of the health industry signifies our position as a leader in improving healthcare diagnostics worldwide.

          Randox – Dedicated to #ImprovingHealth Worldwide

           

                                                                                      


          Randox is shaping the future of clinical diagnostics

          Randox is shaping the future of clinical diagnostics with increased development of innovative technologies. Our passion for innovation, creativity and investment in R&D enables us to continually develop our products and evolve for the future.

          Randox range of biochemistry reagents has developed significantly, from a small selection when our journey began in 1982, to a test menu now comprising of over 116 biomarkers. As the demands of the healthcare industry push for assays which enable the detection of disease probability, and as scientists discover more sensitive and significant biomarkers, we continually add to our reagent range and develop with the needs of the future.

          Not only do we lead the way with a world renowned test menu, we also provide a range of true third party quality controls complimented by our Acusera 24.7 interlaboratory data management system and RIQAS EQA Scheme, guaranteed to simplify QC practice and ensure accurate patient diagnosis. In a world where the prevalence of certain diseases are rife, we understand the importance of correct diagnosis; not only to ensure the right treatment, but also to allow preventative measures to be taken to reduce development of disease. As such, our range of quality controls expands in line with our range of reagents.

          Add the RX series range of clinical chemistry analysers to the mix and we continue to set the benchmark for next generation testing. Providing semi-automated and automated solutions, the RX series is developed with the customer at the forefront; incorporating innovative design, striking performance and personalisation to allow quick throughput to meet growing demands.

          Our position as pioneers in the health industry prevails with our revolutionary biochip array technology and range of biochip analysers. Advancing scientific discovery and personalised health, the biochip allows multiplex testing which can be tailored to your needs.

          Randox’s ability to transition with the demands of the health industry signifies our position as a leader in #FutureDiagnostics.


          History

          Randox Laboratories Founded

          Randox Laboratories Limited is founded by Dr Peter FitzGerald in April 1982

          Reagents in the early years

          Consisted of AST, ALT, ALP, CK-NAC, Gamma GT, LDH and HBDH, all of which are still produced today

          Northern Ireland Institute of Export Award

          Exporter of the Year Award

          Royal visit from HRH Princess Anne

          Visit from Northern Ireland Government Minister for Economic Development

          • Northern Ireland Institute of Export Award
          • SMART Award
          • Northern Ireland Export Award
          • Export Award for Smaller Businesses
          • National Westminster Bank/DTI Travel Award for Shop Floor Worker

          Visit to a now long-standing customer in Syria, the first of many international visits

          • National Westminster Bank/DTI Travel Award for Shop Floor Worker
          • Better Made in Britain Award
          • SMART Award

          1st Queen’s Award for Export Achievement

          • European Business of the Year Award
          • Gallagher Business Challenge Award

          Opening of our first international office, in France

          • Business in Europe Awards

          Opening of office in Portugal

          • 2nd Queen’s Award for Export Achievement

          Began exporting to China, the world’s second largest economy

          • Opening of office in Canada

          Visit to Iraq secured another of our now many international partners. Today we still supply products to Iraq

          • Opening of office in Germany
          • Accredited to ISO 9002
          • SMART Award

          3rd Queen’s Award for Export Achievement

          • Awarded our first patent for biochip

          Mrs FitzGerald is awarded the Order of the British Empire (OBE), for services to business in Northern Ireland

          • Opening of offices in Slovakia, Czech Republic, Spain and the United States of America

          Opening of offices in Poland and Puerto Rico

          Opening of office in Kyrgyzstan

          • Northern Ireland Business Award for International Trade

          We extended our headquarters to facilitate increasing manufacturing demands

          • Accredited to ISO 9001
          • 4th Queen’s Award for Enterprise

          Launch of the first biochip analyser, Evidence

          • Completion of the development of Biochip Array Technology
          • Opening of office in China
          • RIQAS accredited with UKAS approval, the International accreditation for the provision of proficiency testing programmes

          Launch of our first clinical chemistry analyser, RX daytona

          • Royal Academy of Engineering MacRobert Award for the Evidence analyser
          • The Evidence analyser was displayed for a year in the London Science museum after winning the prestigious MacRobert Award
          • Accredited to ISO 13485
          • Launch of Acusera 24-7 Internal Quality Control (IQC) peer group reporting package
          • Royal Academy of Engineering MacRobert Award for the Evidence analyser

          Launch of the second biochip analyser, Evidence Investigator

          • Ernst & Young Entrepreneur of The Year 2004

          Launch of the second clinical chemistry analyser, RX imola

          Launch of the third clinical chemistry analysers, RX monza

          Confederation of British Industry Growing Business Award

          • Chartered Institute of Marketing Award
          • Chamber of Commerce Regional Award
          • Chamber of Commerce Regional Award
          • Frost & Sullivan European Technology Innovation of the Year Award
          • Northern Ireland International Trade Award
          • 5th Queen’s Award for Enterprise International Trade award

          The opening of our site in Dungloe, County Donegal for analyser manufacture and Research & Development

          • Belfast Telegraph Northern Ireland Business Awards

          Launch of the third biochip analyser, Evidence MultiStat which was designed to bring testing to the bedside or site of patient care

          • UTV Business Personality of the Year Award - Dr Peter FitzGerald outright winner
          • South Antrim Business Awards
          • Manufacturing Excellence Awards
          • Invest NI Innovation & Export Awards
          • We were honoured with a second Royal visit by HRH Prince Andrew
          • Total re-branding programme to Randox corporate identity incorporating a red dot symbolising a drop of blood

          Launch of the fourth biochip analyser, Evidence Evolution

          • International Trade Company of the Year Award
          • Exporting Achievement Award
          • Opening of a new facility in West Virginia, USA to expand our manufacturing and distribution capabilities
          • Randox Health Checks Limited was launched in Northern Ireland bringing health screening to the public
          • Marketing Excellence Award: Manufacturing Sector

          Dr Peter FitzGerald is appointed as Commander of the Order of the British Empire (CBE), for services to business in Northern Ireland

          • Launch of the fourth clinical chemistry analyser, RX suzuka
          • Opening of a 30,000 square feet facility in Bangalore, India
          • Launch of two new companies

          Randox Health Checks opens in the centre of London

          • Randoc Health open a state of the art facility to provide a top class testing service which offers a comprehensive picture of health
          • Launch of the fifth clinical chemistry analyser, RX daytona plus

          Randox Biosciences Created

          • Randox invests £15 million in R&D ‘Roadmap’ to target the international personalised medicine market

          Randox unveils new weapon in fight against Flakka

          • Randox create the World’s first test for Flakka

          Randox unveils Evidence MultiSTAT Analyser

          • Randox launches the fully automated immunoanalyser which enables on-site simultaneous detection of up to 44 analytes from a single sample
          • ApoE4 test produced which detects Alzheimer’s risk in 3 hours

          Randox Science Park

          • £161m investment including £29m capital project and creation of 540 jobs

          Randox announced as headline sponsor of Randox Health Grand National

          • Randox announce a 5 year partnership with the world’s greatest race,
          • Randox announces that from its inception in 1982 the global healthcare company has now surpassed £1 billion of total sales in medical diagnostic products, cementing itself as a global market leader in diagnostic goods.
          • Official opening of Randox Health Holywood Clinic

          Partnership with Dana-Farber Cancer Institute Announced

          • Randox Biosciences and Dana-Farber Cancer Institute celebrate success of Transatlantic Partnership in extensive research into life sciences.
          • £7m Biomedical Engineering Laboratory with Ulster University
          • Antimicrobial Array I receives AOAC Certification

          European partnership with French biotech company Transgene, which aims to develop a game-changing therapy for cancer treatments

          • ‘Anti-cancer weapons’ developed in innovative partnership between Randox and Transgene
          • Randox Food Diagnostics unveil Infiniplex for Milk

          £50m Centres of Excellence launched with Invest NI

          • A record £50 million investment which will deliver cutting-edge technologies to diagnose several conditions in collaboration with invest NI
          • Randox announces strategic partnership with Qnostics
          • £5m Industrial PhD Academy with ulster University
          • Official opening of Randox Health Liverpool

          Randox innovations showcased at Goodwood Future Lab

          • Current and futuristic developments showcased at Goodwood displaying how current and future critical health risks can be identified through detailed analysis of blood
          • Dr FitzGerald named as Irish Times Business Person of the Month
          • Dr FitzGerald receives Business Relations Award from Ireland-US Council

          Randox and Ulster University team up for major student sports sponsorship deal

          The investment from Randox will supply kit and equipment for 70 sports clubs across the university’s four campuses, including individual and team sports such as basketball, GAA, hockey, football, athletics and more. As of 2021, 5000 students have taken part in sports club activities and more than 3000 students have worn a Randox jersey.

          New test developed for accurate differentiation of stroke types

          • The ground-breaking new test which has a unique ability to differentiate between ischaemic and haemorrhagic stroke, the Randox Stroke Biochip takes less than 30 minutes to complete – making sure patients get the right diagnosis as fast as possible.
          • RX Daytona+ achieves FDA 510K clearance
          • Randox Food named as Top 10 European Food and Beverage Technology Solution Provider

          Randox playing integral role in UK Government’s national COVID-19 testing programme

          • Randox are playing a leading role within the fight against the COVID-19 global pandemic, as an integral part of the national testing programme Randox have invested £30m in a new COVID-19 testing laboratory at the Randox Science Park in Northern Ireland.
          • CE Marking for 10-Plex STI Array, Quickly and efficiently testing for multiple STIs, which often have mild symptoms if any at all, ensures early diagnosis at a stage when treatment is most successful, supports the targeted use of antibiotics, and ultimately reduces their mishandling

          Randox unveils SARS-CoV-2 antibody test to determine previous COVID-19 infection

          Randox launch new SARS-CoV-2 IgG test, utilising patented Randox Biochip Technology to simultaneously detect IgG antibodies that are reactive to both of the leading COVID-19 diagnostic antigens – Spike Receptor Binding Domain (RBD) and Nucleocapsid protein (NP) , and superior to other commercially available COVID-19 IgG tests.

          Covid Travel Testing

          Randox launch travel testing service at key airport locations across the UK and Ireland, offering rapid PCR tests for those who require a negative test before travelling. The service delivers test results within 48 hours of sample receipt, to provide passengers with a cost-effective, fast and reliable COVID-19 testing service prior to their travels.

          New 39-minute COVID test is now available on the Vivalytic

          Point of care platforms brought to the market by Randox Laboratories and Bosch Healthcare Solutions, deliver one of the worlds fastest CE marked PCR based SARS-CoV-2 results, in just 39 minutes. With pooling cartridges available to offer simultaneous detection of multiple patient samples on one single cartridge.

          Mobile COVID-19 Labs

          Randox launch Mobile COVID-19 Labs for workplace testing. The service offers rapid and reliable COVID-19 testing to workplaces with capability to process up to 1000 samples per day.

          Randox extends Grand National Festival Sponsorship for a further five years

          Randox secured an agreement with The Jockey Club for a five-year extension to the sponsorship of the world’s greatest steeplechase, The Grand National, and the three-day Grand National Festival staged at Aintree Racecourse.

          The Randox VeraSTAT launched

          A new addition as of 2021, the VeraSTAT offers a simple, accurate, fast and portable point of care device based on cathodic electrochemiluminescence technology. Designed to offer users the next generation of rapid diagnosis, providing results in as little as 6 minutes.

          Introducing the new VeraSTAT-V

          Another new addition in 2021, the Randox VeraSTAT-V has been designed to detect the earliest signs of inflammation in veterinary diagnosis. Building upon the fond attachment Randox has with the equestrian world through the sponsorship of the Aintree Grand National, the VeraSTAT-V is a stable-side device designed to detect, measure, and monitor inflammation in whole horse blood.

          Randox sign principal partnership with Sheffield United FC

          Randox announce the signing of a three-year principle partnership agreement with Sheffield United. Commencing in the 2021/22 season, the deal includes both men’s and women’s first teams, with both wearing the Randox logo on their jerseys.

          Gold standard testing for Team GB

          Randox sign a two-year partnership with Team GB, providing Covid-19 testing for the summer and winter games. Including Tokyo 2020 and Beijing 2022.

          The newly named Randox Health Academy

          Randox and Sheffield United further strengthen their partnership to include naming rights of Sheffield United’s Academy. With almost 40 years of experience in the manufacture of world-leading medical diagnostics and sports science services, Randox is well positioned to assist in the development of the health, wellbeing, and performance of the next generation of male and female players.

          A slam-dunking new partnership between Randox Laboratories and Olimpia Milano

          Randox announced as the Official Diagnostics Partner of Olimpia Milano basketball team. The deal provides the sporting institution access to Randox’s technology to perform a variety of health testing on Olimpia’s athletes and wider support staff.

          Randox design SARS-CoV-2 RBD & NP array

          The Randox CE marked SARS-CoV-2 IgG RBD & NP array utilises patented biochip technology to simultaneously detect IgG antibodies against both leading COVID-19 diagnostic antigens; Spike Receptor Binding Domain (RBD) and Nucleocapsid protein (NP). The SARS-CoV-2 IgG (RBD & NP) array is compatible with both capillary and venous blood collection.

          Randox develop SARS-CoV-2 Neutralising Assays

          The Randox CE marked Sars-CoV-2 neutralising assays measures neutralising antibodies to Wild Type (Wuhan), Delta & Omicron variants following vaccination or natural infection. Wild Type Surrogate Virus Neutralisation Assay and Delta SARS-CoV-2 Surrogate Virus Neutralisation Assay detect antibodies that block interaction of the spike protein receptor-binding domain (RBD) and angiotensin-converting enzyme 2 (ACE2). Randox Laboratories currently have in development an assay designed to detect antibodies against SARS-CoV-2 Omicron variant.

          Randox announce Variants of Concern Panel

          The Randox CE marked SARS-CoV-2 IgG RBD & NP array utilises patented biochip technology to simultaneously detect IgG antibodies against both leading COVID-19 diagnostic antigens; Spike Receptor Binding Domain (RBD) and Nucleocapsid protein (NP). The SARS-CoV-2 IgG (RBD & NP) array is compatible with both capillary and venous blood collection.

          Randox announced as Official Supplier of UAE Team Emirates

          The agreement between Randox and the two time Tour de France winners will see Team UAE utilise the Vivalytic, a point of care platform brought to the market by Randox Laboratories and Bosch Healthcare Solutions. Testing team riders and wider support staff for COVID prior to upcoming races and tours.

          Randox to deliver £10m investment for major UK research project with our future health

          Randox has been announced as one of four new industry partners in the Our Future Health (OFH) programme, which will be the UK’s largest ever health research programme. Randox will deliver a £10m investment in the programme, which will discover and develop new methods of prevention, early detection and treatment of diseases and health conditions.

          Randox collaborate with Verv Technologies to improve health for all

          Randox Laboratories are the lead investor for Verv Technologies, who are focused on creating the first of its kind consumer-oriented, affordable, high-quality blood chemistry analyser with disposable tests for home use, that will help individuals measure a wide range of analytes (i.e., cholesterol, vitamin levels, hormones). With over 40 years of diagnostic experience, Randox Laboratories are focused on investment into technologies to improve health for all.

          Randox Health expands across the UK & Republic of Ireland

          Canary Wharf is the latest in a national roll-out programme of 20 Randox Health clinics, with many more planned, bringing the world’s most advanced and personalised Health Programme directly to the consumer.

          Randox Laboratories and Roquefort Therapeutics Collaborate to Develop Midkine Cancer Antibodies

          Randox Laboratories collaborate with Roquefort Therapeutics, an LSE market listed biotech company, dedicated to developing first in class medicines in the high value, high growth oncology market. The partnership is focused on the field of medical diagnostics only, in relation to Roquefort’s Midkine antibody portfolio.

          Randox Health partners with Reviv to expand

          This partnership with REVIV, who championed commercialised IV therapy, will allow people to see real-time results from taking steps to protect their health and to experience the future of wellness.

          Randox acquires microfluidic tools and impedence flow cytometer developer, Cellix Limited

          This acquisition expands Randox’s technical capabilities into the benchtop flow cytometry space aligning with their commitment to personalised medicine and improved preventative healthcare.

          Team GB Official Health Diagnostics partner

          The British Olympic Association (BOA) revealed that Randox Health will serve as the Official Diagnostic Health Partner for Team GB leading up to the Paris 2024 Olympic Games. Building on the triumph of their prior collaboration, during which Randox offered Covid-19 testing services for both the Tokyo 2020 and Beijing 2022 Olympics, this fresh partnership aims to revolutionise the nation’s perspective on health.

          Randox Feedback Survey


          Request a meeting
          ×
          Make an Enquiry - RX series
          ×
          Make an Enquiry - Reagents
          ×
          Kit Insert Request - Reagents
          • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
          ×
          Kit Insert Request - Reagents
          • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
          ×
          Make an Enquiry - Reagents
          ×
          Make an Enquiry - Quality Control
          ×
          Make an Enquiry - RIQAS
          ×
          Make an Enquiry - RIQAS
          ×
          Make an Enquiry - Quality Control
          ×
          Make an Enquiry
          • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
          ×
          Make an Enquiry - Biochip
          • This field is for validation purposes and should be left unchanged.
          ×
          Make an Enquiry - Molecular
          • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
          • This field is for validation purposes and should be left unchanged.
          ×
          Make an Enquiry - Future Diagnostics
          ×
          Make an Enquiry - RX series (Product)
          ×
          Make an Enquiry - Quality Control
          • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
          ×
          Make an Enquiry - RIQAS
          • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
          ×
          Make an Enquiry - Reagents
          • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
          ×
          Por favor, introduzca sus datos para ver nuestro Ćŗltimo seminario
          ×
          Wyślij zapytanie
          • Rejestracja na naszej liście mailowej jest szybka i łatwa. Nie chcemy wysyłać e-maili zawierających spam lub wiadomości, ktĆ³re są automatycznie przekierowywane do kosza. W zawiązku z czym firma Randox deklaruje, że będzie wysyłac tylko informacje na temat nowych produktĆ³w,akutalizacji obecnych, trendĆ³w rynkowych, wydarzeń branżowych itp. Firma Randox Laboraotries obiecuje, że Państwa dane nie będą nigdzie przekazane, a przechowywanie owych danych będzie się odbywało z zachowaniem największego bezpieczeństwa. Prosimy o przeczytani naszje Polityki Prywatności.
          ×
          Wyślij zapytanie
          • Rejestracja na naszej liście mailowej jest szybka i łatwa. Nie chcemy wysyłać e-maili zawierających spam lub wiadomości, ktĆ³re są automatycznie przekierowywane do kosza. W zawiązku z czym firma Randox deklaruje, że będzie wysyłac tylko informacje na temat nowych produktĆ³w,akutalizacji obecnych, trendĆ³w rynkowych, wydarzeń branżowych itp. Firma Randox Laboraotries obiecuje, że Państwa dane nie będą nigdzie przekazane, a przechowywanie owych danych będzie się odbywało z zachowaniem największego bezpieczeństwa. Prosimy o przeczytani naszje polityki prywatności.
          ×
          Wyślij zapytanie
          • Rejestracja na naszej liście mailowej jest szybka i łatwa. Nie chcemy wysyłać e-maili zawierających spam lub wiadomości, ktĆ³re są automatycznie przekierowywane do kosza. W zawiązku z czym firma Randox deklaruje, że będzie wysyłac tylko informacje na temat nowych produktĆ³w,akutalizacji obecnych, trendĆ³w rynkowych, wydarzeń branżowych itp. Firma Randox Laboraotries obiecuje, że Państwa dane nie będą nigdzie przekazane, a przechowywanie owych danych będzie się odbywało z zachowaniem największego bezpieczeństwa. Prosimy o przeczytani naszje polityki prywatności.
          ×
          Wyślij zapytanie
            Rejestracja na naszej liście mailowej jest szybka i łatwa. Nie chcemy wysyłać e-maili zawierających spam lub wiadomości, ktĆ³re są automatycznie przekierowywane do kosza. W zawiązku z czym firma Randox deklaruje, że będzie wysyłac tylko informacje na temat nowych produktĆ³w,akutalizacji obecnych, trendĆ³w rynkowych, wydarzeń branżowych itp. Firma Randox Laboraotries obiecuje, że Państwa dane nie będą nigdzie przekazane, a przechowywanie owych danych będzie się odbywało z zachowaniem największego bezpieczeństwa. Prosimy o przeczytani naszje polityki prywatności .
          ×
          ź·€ķ•˜ģ˜ ė¬øģ˜ ģ‚¬ķ•­ ģ œģ¶œ
            Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
          ×
          ź·€ķ•˜ģ˜ ė¬øģ˜ ģ‚¬ķ•­ ģ œģ¶œ
          ×
          ź·€ķ•˜ģ˜ ė¬øģ˜ ģ‚¬ķ•­ ģ œģ¶œ
          ×
          ź·€ķ•˜ģ˜ ė¬øģ˜ ģ‚¬ķ•­ ģ œģ¶œ
          ×
          Downloads
          ×
          Contact

          <p>

            Randox Clinical Chemistry Products Join the Randox Laboratories Mailing List * I would like to receive emails with new product releases and updates from Randox Laboratories, market trends, and more. I do not want to receive email marketing from Randox. Signing up to our mailing list is quick and easy. We do not want to send you any spam or junk emails, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promises never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
          </p>

          ×
          Enquire Now - Coronavirus Testing
          • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details safe and secure. Read more in our Privacy Policy.
          ×